These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8799521)

  • 1. Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients.
    Bleck JS; Thiesemann C; Kliem V; Christians U; Hecker H; Repp H; Frei U; Westhoff-Bleck M; Manns M; Sewing KF
    Br J Clin Pharmacol; 1996 Jun; 41(6):551-6. PubMed ID: 8799521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem.
    Aros CA; Ardiles LG; Schneider HO; Flores CA; Alruiz PA; Jerez VR; Mezzano SA
    Transplant Proc; 2005 Oct; 37(8):3364-6. PubMed ID: 16298597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].
    Sperschneider H; Wagner C; Korn A; Christians U
    Med Klin (Munich); 1997 Oct; 92(10):589-96. PubMed ID: 9446006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are cytochrome P450 3A enzymes in the small intestine responsible for different cyclosporine metabolite patterns in stable male and female renal allograft recipients after co-administration of diltiazem?
    Christians U; Bleck JS; Lampen A; Bader A; Thiesemann C; Kliem V; Repp H; Westhoff-Bleck M; Manns M; Sewing KF
    Transplant Proc; 1996 Aug; 28(4):2159-61. PubMed ID: 8769186
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants.
    Foradori A; Mezzano S; Videla C; Pefaur J; Elberg A
    Transplant Proc; 1998 Aug; 30(5):1685-7. PubMed ID: 9723244
    [No Abstract]   [Full Text] [Related]  

  • 6. Diltiazem-cyclosporin pharmacokinetic interaction--dose-response relationship.
    Jones TE; Morris RG; Mathew TH
    Br J Clin Pharmacol; 1997 Nov; 44(5):499-504. PubMed ID: 9384468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative cyclosporine metabolic pathways and toxicity.
    Christians U; Sewing KF
    Clin Biochem; 1995 Dec; 28(6):547-59. PubMed ID: 8595701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients.
    Jones TE; Morris RG
    Clin Pharmacokinet; 2002; 41(5):381-8. PubMed ID: 12036394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diltiazem does not always increase blood cyclosporin concentration.
    Jones TE; Morris RG
    Br J Clin Pharmacol; 1996 Nov; 42(5):642-4. PubMed ID: 8951199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitus.
    Akhlaghi F; Dostalek M; Falck P; Mendonza AE; Amundsen R; Gohh RY; Asberg A
    Ther Drug Monit; 2012 Feb; 34(1):38-45. PubMed ID: 22210099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Between C2 and AUC(0-4) in Renal Transplant Patients Treated With Diltiazem.
    Aros CA; Schneider HO; Flores CA; Ardiles LG; Alruiz PA; Jerez V; Mezzano SA
    Transplant Proc; 2005 Apr; 37(3):1580-2. PubMed ID: 15866679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of the diltiazem with oral and intravenous cyclosporine in rats.
    Kalkan S; Gumustekin M; Aygoren O; Tuncok Y; Gelal A; Guven H
    Eur J Drug Metab Pharmacokinet; 2004; 29(2):119-23. PubMed ID: 15230340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients.
    Smith CL; Hampton EM; Pederson JA; Pennington LR; Bourne DW
    Pharmacotherapy; 1994; 14(4):471-81. PubMed ID: 7937285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approach.
    McLachlan AJ; Tett SE
    Ther Drug Monit; 1998 Aug; 20(4):390-5. PubMed ID: 9712463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of calcium antagonists on hemodynamics and cyclosporine pharmacokinetics in heart-transplant and kidney-transplant patients.
    Roy LF; East DS; Browning FM; Shaw D; Ogilvie RI; Cardella C; Leenen FH
    Clin Pharmacol Ther; 1989 Dec; 46(6):657-67. PubMed ID: 2689045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of a dose-response of cyclosporine levels to clinically used doses of diltiazem and verapamil.
    Jacob LP; Malhotra D; Chan L; Shapiro JI
    Am J Kidney Dis; 1999 Feb; 33(2):301-3. PubMed ID: 10023642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients.
    Hermann M; Asberg A; Christensen H; Reubsaet JL; Holdaas H; Hartmann A
    Eur J Clin Pharmacol; 2005 Mar; 61(1):59-62. PubMed ID: 15711834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bioavailability and metabolism with two commercial formulations of cyclosporine a in rats.
    Koehler J; Kuehnel T; Kees F; Hoecherl K; Grobecker HF
    Drug Metab Dispos; 2002 Jun; 30(6):658-62. PubMed ID: 12019192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.